Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio, M; Lhomme, E; Kieh, M; Beavogui, AH; Kennedy, SB; Doumbia, S; Leigh, B; Sow, SO; Diallo, A; Fusco, D; Kirchoff, M; Termote, M; Vatrinet, R; Wentworth, D; Esperou, H; Lane, HC; Pierson, J; Watson-Jones, D; Roy, C; D'Ortenzio, E; GREENWOOD, B; Chêne, G; Richert, L; Neaton, JD; Yazdanpanah, Y; ... PREVAC study team,
2021
Trials, (2021).22 1 10.1186/s13063-021-05035-9.
Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy.
BENEST, J; RHODES, S; QUAIFE, M; Evans, TG; WHITE, RG;
2021
Vaccines, (2021).9 2 10.3390/vaccines9020078.
Regulation of the human NK cell compartment by pathogens and vaccines.
GOODIER, MR; Riley, EM;
2021
Clinical & Translational Immunology, (2021).10 1 10.1002/cti2.1244.
RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... Hatherill, M.
2021
, University of Cape Town (2021).
RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... Hatherill, M.
2021
, University of Cape Town (2021).
Author Correction: A global survey of potential acceptance of a COVID-19 vaccine.
Lazarus, JV; Ratzan, SC; Palayew, A; Gostin, LO; LARSON, HJ; Rabin, K; Kimball, S; El-Mohandes, A;
2021
Nature medicine, (2021).27 2 10.1038/s41591-020-01226-0.
How can the public health impact of vaccination be estimated?.
Londono, SE; Li, X; Toor, J; Villiers, MD; Nayagam, S; Hallett, T; Abbas, K; JIT, M; KLEPAC, P; Jean, K; Garske, T; Ferguson, N; Gaythorpe, K;
2021
medRxiv (2021). 10.1101/2021.01.08.21249378.
Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali.
Mahamar, A; Issiaka, D; Youssouf, A; Niambele, SM; Soumare, HM; Attaher, O; Barry, A; Narum, DL; Duffy, PE; GREENWOOD, B; Fried, M; Dicko, A;
2021
Malaria journal, (2021).20 1 10.1186/s12936-020-03542-9.
COVID-19's lost generation of unvaccinated children - Authors' reply.
ABBAS, K; PROCTER, SR; CLARK, A; FLASCHE, S;
2021
The Lancet. Global health, (2021).9 3 10.1016/S2214-109X(20)30537-4.
A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial.
BAISLEY, KJ; WHITWORTH, HS; Changalucha, J; Pinto, L; Dillner, J; KAPIGA, S; De Sanjosé, S; MAYAUD, P; HAYES, RJ; Lacey, CJ; WATSON-JONES, D;
2021
Contemporary clinical trials, (2021).101, 10.1016/j.cct.2021.106266.